Kintsugi’s AI Software Analyzes Voice For Signs Of Depression, Anxiety

05 Apr 2023

Kintsugi is developing an AI-driven software that analyzes voice to detect depression and anxiety, offering clinicians an early screening tool in call centers, telehealth and remote monitoring.

Kintsugi CEO Grace Chang is hopeful that the company’s voice biomarkers technology for detecting depression and anxiety from short clips of free speech will receive the nod of approval from US regulators. (Also see "CES 2022: Defying Omicron, World’s Biggest Tech Show Goes Live In Las Vegas" - Medtech Insight, 6 January, 2022.)

The software has been already integrated for further evaluation in call centers, telehealth services and remote monitoring apps to screen...